Japan: Cannsun establishes JV with Shigeru to distribute in Asia

Medical Cannabis

Dublin-based Cannsun Group, a bio-pharmaceutical company with operations in South Africa, Greece, Japan, Thailand and Lesotho has established a joint venture with Tokyo-based Shigeru private equity. The JV, Cannsun Medhel Japan, will distribute Cannsun products including pharmaceuticals, cosmetics and food supplements throughout Japan, China and other Asian countries. It will develop additional R&D partnerships in…

You must be a HMI Subscriber to view this content.

Subscribe Now »